Literature DB >> 311475

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.

P A Neighbour, B R Bloom.   

Abstract

Lymphocytes from normal adult donors exposed in vitro to inactivated measles virus were found to exert significant suppression (33.9%) of the concanavalin A responses of cryopreserved, autochthonous responder cells. In marked contrast, lymphocytes from multiple sclerosis patients exhibited significantly reduced suppression (1.5%), and in 80% of cases failed to suppress at all. The degree of suppression increased slightly with age of the patient but did not vary with the clinical stage of disease. There was no apparent genetic restriction of suppressor activity. Although specificity of this phenomenon for measles virus has not been established, no differences in the responses of lymphocytes from normal or multiple sclerosis patient donors were found with subacute sclerosing panencephalitis, Sendai, canine distemper, mumps, or influenza viruses. Supernates of measles-treated lymphocytes from normal donors possessed both suppressive and antiviral activities. Both activities were resistant to pH 2 treatment and were neutralized by an anti-human leukocyte interferon antiserum, strongly suggesting that interferon (probably type I) was the mediator of suppression. Consistent with their inability to suppress concanavalin A responses, lymphocytes from multiple sclerosis patients failed to produce significant amounts of interferon in response to measles challenge in vitro. These results extend previous observations that multiple sclerosis patients are unable to respond appropriately to measles virus antigen in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311475      PMCID: PMC382964          DOI: 10.1073/pnas.76.1.476

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

Authors:  B R Brodeur; T C Merigan
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens.

Authors:  L B Epstein; H W Kreth; L A Herzenberg
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

3.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

4.  Effect of phytohemagglutinin, basic protein and measles antigen on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes from patients with multiple sclerosis.

Authors:  H Offner; G Konat; J Clausen
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

5.  Poliovirus replication and cytopathogenicity in monolayer hamster cell cultures fused with beta propiolactone-inactivated Sendai virus.

Authors:  J M Neff; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

6.  Effect of priming on interferon inhibition of con A induced spleen cell blastogenesis.

Authors:  K R Rozes; S H Lee; J Ngan
Journal:  Nat New Biol       Date:  1973-09-05

7.  Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy.

Authors:  L Horta-Barbosa; D A Fuccillo; J L Sever; W Zeman
Journal:  Nature       Date:  1969-03-08       Impact factor: 49.962

8.  Multiple sclerosis and parainfluenza 1 virus. History of the isolation of the virus and expression of phenotypic differences between the isolated virus and Sendai virus.

Authors:  H Koprowski; V ter Meulen
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

9.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  A suppression of cellular immunity in patients with multiple sclerosis.

Authors:  V Utermohlen; J B Zabriskie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Effects of experimental recombinant interferons on multiple sclerosis.

Authors:  K P Johnson; H S Panitch
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

2.  Measles virus inhibits lymphocyte proliferation in vitro by two different mechanisms.

Authors:  R Salonen; J Ilonen; A A Salmi
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 3.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis.

Authors:  R J Abbott; P D Giles; I Bolderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

5.  Interferon deficiency syndrome.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

Authors:  I O Auer; E Ziemer; H Sommer
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

Review 7.  Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

Authors:  D E Goodkin
Journal:  West J Med       Date:  1994-09

8.  Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.

Authors:  J Merrill; M Jondal; J Seeley; M Ullberg; A Sidén
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

9.  Modulation of T-lymphocyte differentiation antigens: potential relevance for multiple sclerosis.

Authors:  J Antel; J J Oger; S Jackevicius; H H Kuo; B G Arnason
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.